A novel Nrf2 activator from microbial transformation inhibits radiation-induced dermatitis in mice
about
Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson's Disease: Rationale for Clinical Trial, and Current Progress.Targeting NRF2 for Improved Skin Barrier Function and Photoprotection: Focus on the Achiote-Derived Apocarotenoid Bixin.Topical Bixin Confers NRF2-Dependent Protection Against Photodamage and Hair Graying in Mouse Skin.
P2860
A novel Nrf2 activator from microbial transformation inhibits radiation-induced dermatitis in mice
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A novel Nrf2 activator from mi ...... ion-induced dermatitis in mice
@en
A novel Nrf2 activator from mi ...... on-induced dermatitis in mice.
@nl
type
label
A novel Nrf2 activator from mi ...... ion-induced dermatitis in mice
@en
A novel Nrf2 activator from mi ...... on-induced dermatitis in mice.
@nl
prefLabel
A novel Nrf2 activator from mi ...... ion-induced dermatitis in mice
@en
A novel Nrf2 activator from mi ...... on-induced dermatitis in mice.
@nl
P2860
P356
P1476
A novel Nrf2 activator from mi ...... ion-induced dermatitis in mice
@en
P2093
Kayoko Masuda
Yasuhiro Nakagami
P2860
P304
P356
10.1093/JRR/RRW039
P577
2016-05-29T00:00:00Z